[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

ES2054333T3 - Forma de dosificacion para administrar un antagonista del calcio. - Google Patents

Forma de dosificacion para administrar un antagonista del calcio.

Info

Publication number
ES2054333T3
ES2054333T3 ES90901388T ES90901388T ES2054333T3 ES 2054333 T3 ES2054333 T3 ES 2054333T3 ES 90901388 T ES90901388 T ES 90901388T ES 90901388 T ES90901388 T ES 90901388T ES 2054333 T3 ES2054333 T3 ES 2054333T3
Authority
ES
Spain
Prior art keywords
administer
dosage form
calcium antagonist
nicardipine
patient
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90901388T
Other languages
English (en)
Inventor
Joseph C Deters
David R Swanson
Rosa Stephen C De
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alza Corp
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alza Corp filed Critical Alza Corp
Application granted granted Critical
Publication of ES2054333T3 publication Critical patent/ES2054333T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004—Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

SE PRESENTA UNA FORMA DE DOSIFICACION (10) QUE CONSTA DE UN MIEMBRO SELECCIONADO DEL GRUPO QUE CONSISTE EN NICARDIPINA Y SUS SALES FARMACEUTICAMENTE ACEPTABLES PARA ADMINISTRARLOS A UN PACIENTE QUE NECESITA UNA TERAPIA CARDIOVASCULAR.
ES90901388T 1989-01-30 1989-12-18 Forma de dosificacion para administrar un antagonista del calcio. Expired - Lifetime ES2054333T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US30370689A 1989-01-30 1989-01-30

Publications (1)

Publication Number Publication Date
ES2054333T3 true ES2054333T3 (es) 1994-08-01

Family

ID=23173326

Family Applications (2)

Application Number Title Priority Date Filing Date
ES90901388T Expired - Lifetime ES2054333T3 (es) 1989-01-30 1989-12-18 Forma de dosificacion para administrar un antagonista del calcio.
ES9000257A Expired - Fee Related ES2026304A6 (es) 1989-01-30 1990-01-29 Procedimiento de fabricacion de una forma de dosificacion de nicardipina.

Family Applications After (1)

Application Number Title Priority Date Filing Date
ES9000257A Expired - Fee Related ES2026304A6 (es) 1989-01-30 1990-01-29 Procedimiento de fabricacion de una forma de dosificacion de nicardipina.

Country Status (11)

Country Link
EP (1) EP0455648B1 (es)
JP (1) JPH04503058A (es)
AU (1) AU621182B2 (es)
CA (1) CA2007106A1 (es)
DK (1) DK23790A (es)
ES (2) ES2054333T3 (es)
FI (1) FI913608A0 (es)
GR (1) GR1000419B (es)
IE (1) IE61872B1 (es)
PT (1) PT92994B (es)
WO (1) WO1990008536A1 (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ238867A (en) * 1990-07-12 1993-08-26 Alza Corp Dosage form for delayed release comprising pharmaceutically active substance and a drug-release hindering means and a second composition which imbibes fluid, expands, and ejects the active substance from the device
US5156850A (en) * 1990-08-31 1992-10-20 Alza Corporation Dosage form for time-varying patterns of drug delivery
US5654005A (en) * 1995-06-07 1997-08-05 Andrx Pharmaceuticals, Inc. Controlled release formulation having a preformed passageway
PT1035834E (pt) * 1997-12-05 2002-09-30 Alza Corp Forma de dosagem osmotica que compreende primeiro e segundo revestimentos
ES2221370T3 (es) 1998-04-03 2004-12-16 Egalet A/S Composicion de liberacion controlada.
WO2003024430A1 (en) 2001-09-21 2003-03-27 Egalet A/S Morphine polymer release system
US20040234602A1 (en) 2001-09-21 2004-11-25 Gina Fischer Polymer release system
AU2003275953A1 (en) 2002-11-08 2004-06-07 Egalet A/S Controlled release carvedilol compositions
EP1610767B1 (en) 2003-03-26 2011-01-19 Egalet A/S Morphine controlled release system
JP4989217B2 (ja) 2003-03-26 2012-08-01 エガレット エイ／エス 薬剤物質の送達制御用マトリックス組成物
WO2006030402A2 (en) * 2004-09-17 2006-03-23 Ranbaxy Laboratories Limited Dual compartment osmotic delivery device
DE602006003639D1 (de) * 2005-01-27 2008-12-24 Alza Corp Orale osmotische darreichungsform mit membran mit hoher flussdichte
US8821928B2 (en) 2007-06-04 2014-09-02 Egalet Ltd. Controlled release pharmaceutical compositions for prolonged effect
EP2393484A1 (en) 2009-02-06 2011-12-14 Egalet Ltd. Immediate release composition resistant to abuse by intake of alcohol
CA2766179A1 (en) 2009-06-24 2010-12-29 Egalet Ltd. Controlled release formulations
KR20150059167A (ko) 2012-07-06 2015-05-29 에갈렛 리미티드 제어된 방출을 위한 남용 제지 약학적 조성물

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4519801A (en) * 1982-07-12 1985-05-28 Alza Corporation Osmotic device with wall comprising cellulose ether and permeability enhancer
US4783337A (en) * 1983-05-11 1988-11-08 Alza Corporation Osmotic system comprising plurality of members for dispensing drug
US4753802A (en) * 1986-03-19 1988-06-28 Alza Corporation Verapamil dosage form

Also Published As

Publication number Publication date
DK23790D0 (da) 1990-01-29
ES2026304A6 (es) 1992-04-16
AU4811490A (en) 1990-08-24
IE900296L (en) 1990-07-30
EP0455648A1 (en) 1991-11-13
GR1000419B (el) 1992-06-30
PT92994B (pt) 1995-12-29
WO1990008536A1 (en) 1990-08-09
FI913608A0 (fi) 1991-07-29
EP0455648B1 (en) 1993-03-10
PT92994A (pt) 1990-07-31
CA2007106A1 (en) 1990-07-30
GR900100015A (en) 1991-06-07
AU621182B2 (en) 1992-03-05
JPH04503058A (ja) 1992-06-04
DK23790A (da) 1990-07-31
IE61872B1 (en) 1994-11-30

Similar Documents

Publication Publication Date Title
ES2054333T3 (es) Forma de dosificacion para administrar un antagonista del calcio.
DK0494972T3 (da) Brusedosisform samt fremgangsmåde til administration heraf
ES2139132T3 (es) Composiciones farmaceuticas activas en la terapia de desordenes del sueño.
ATE211387T1 (de) Oral 1alpha-hydroxyprevitamin d
FI920956A0 (fi) Doseringsform foer administrering av oral hypoglykemisk glipisid.
CO4340681A1 (es) Procedimientos de uso para la inhibicion de la perdida osea y la disminucion del colesterol en suero
AR008878A1 (es) Antagonistas del receptor de vitronectina, un metodo para su preparacion, una composicion farmaceutica que los contiene y el uso de las mismas para la preparacion de un medicamento.
FI925342A (fi) Menetelmä terapeuttisesti aktiivisen (+)- -(2,3-dimetoksifenyyli)-1-/2-(4-fluorifenyyli)etyyli/-4-piperidiinimetanolin valmistamiseksi
NO920946L (no) Oral antikoagulant/blodplateinhibitor i lavdoseformulering
ZA926241B (en) Dosage form for delivering drug in short-time period
CY1112361T1 (el) Σκευασματα για αντικαρκινικη θεραπεια που περιεχουν εκτεϊνασκιδινη 743
NO306377B1 (no) Doseform for avgivelse av et medikament
ES2034035T3 (es) Procedimiento de preparacion de una forma farmaceutica para la administracion y/o dosificacion de medicamentos.
ES2130152T3 (es) Medicamentos para tratar dolencias inflamatorias o para analgesia que contienen un nsaid y ranitidina/citrato de bismuto.
ES2188663T3 (es) Uso de productos que contienen magnesio para el tratamiento o profilaxis de enfermedades neoplasicas o autoinmunes.
ES2135342B1 (es) Uso del raloxifeno o una sal o salvato del mismo en la preparacion de un medicamento para prevenir el cancer de mama.
ES2020171T3 (es) Eteres de 1-bencil-3-hidroximetilindazol con 2-hidroxiacidos alifaticos.
ES2089286T3 (es) Nuevas 2-amino-5-ciano-1,4-dihidropiridinas, procedimiento para su preparacion y su uso en medicamentos.
ES2043943T3 (es) Procedimiento para la preparacion de compuestos con actividad analgesica central.
ES2110551T3 (es) Empleo de l-carnitina y acil l-carnitinas para tratamiento de pacientes que padecen sindromes relacionados con el sida y pacientes de hiv seropositivos asintomaticos.
AR023452A1 (es) Utilizacion del osanetant para preparacion de medicamentos utiles en el tratamiento de los trastornos del humor
ES2043736T3 (es) Acidos 3,5-dihidroxi-heptanoicos sustituidos con (1h-pirrol-3-ilo) en posicion 7, sus correspondientes delta-lactonas y sales, procedimientos para su preparacion, su utilizacion como medicamentos, preparados farmaceuticos y productos intermedios.
DK400887D0 (da) Anvendelse af 15-deoxyspergualin til fremstilling af et laegemiddel
MX9203735A (es) Una forma de dosis mejorada para suministrar una droga o un agente terapeutico a un ambiente de uso.
LV11524A (lv) Benzidamina izmantosana TNF izsaukto patologisko stavoklu arstesana

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 455648

Country of ref document: ES